You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

hdm201

Showing 1 - 7 of 7
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

AML, Adult Trial in Berne (HDM201, Midostaurin)

Terminated
  • AML, Adult
  • Berne, Switzerland
    Departement of Medical Oncology, University Hospital Berne
Oct 3, 2022

Acute Myeloid Leukemia (AML), High-risk Myelodysplastic Syndrome (MDS) Trial in Worldwide (HDM201, MBG453, Venetoclax)

Active, not recruiting
  • Acute Myeloid Leukemia (AML)
  • High-risk Myelodysplastic Syndrome (MDS)
  • HDM201
  • +2 more
  • Durham, North Carolina
  • +8 more
Dec 13, 2022

Advanced Soft-tissue Sarcoma, Metastatic Soft-tissue Sarcoma Trial in France (Pazopanib, HDM201)

Recruiting
  • Advanced Soft-tissue Sarcoma
  • Metastatic Soft-tissue Sarcoma
  • Bordeaux, France
  • +4 more
May 5, 2022

Advanced Solid and Hematological TP53wt Tumors Trial in Worldwide (HDM201, ancillary treatment)

Completed
  • Advanced Solid and Hematological TP53wt Tumors
  • HDM201
  • ancillary treatment
  • Boston, Massachusetts
  • +14 more
May 20, 2021

Liposarcoma Trial in Worldwide (HDM201, LEE011)

Completed
  • Liposarcoma
  • Toronto, Ontario, Canada
  • +8 more
Dec 6, 2020

Colorectal Cancer, Non-small Cell Lung Carcinoma (Adenocarcinoma), Triple Negative Breast Cancer, Renal Cell Carcinoma Trial in

Completed
  • Colorectal Cancer, Non-small Cell Lung Carcinoma (Adenocarcinoma), Triple Negative Breast Cancer, Renal Cell Carcinoma
  • PDR001
  • +5 more
  • Santa Monica, California
  • +24 more
Mar 11, 2022

Leukemia, Myeloid, Acute Trial (HDM201, cytarabine, anthracycline)

Withdrawn
  • Leukemia, Myeloid, Acute
  • HDM201
  • +6 more
  • (no location specified)
Jan 6, 2020